IBDEI0LP ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9765,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,9765,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,9766,0)
 ;;=R87.613^^39^417^53
 ;;^UTILITY(U,$J,358.3,9766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9766,1,3,0)
 ;;=3^HGSIL
 ;;^UTILITY(U,$J,358.3,9766,1,4,0)
 ;;=4^R87.613
 ;;^UTILITY(U,$J,358.3,9766,2)
 ;;=^5019671
 ;;^UTILITY(U,$J,358.3,9767,0)
 ;;=R87.612^^39^417^63
 ;;^UTILITY(U,$J,358.3,9767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9767,1,3,0)
 ;;=3^LGSIL
 ;;^UTILITY(U,$J,358.3,9767,1,4,0)
 ;;=4^R87.612
 ;;^UTILITY(U,$J,358.3,9767,2)
 ;;=^5019670
 ;;^UTILITY(U,$J,358.3,9768,0)
 ;;=R92.1^^39^417^66
 ;;^UTILITY(U,$J,358.3,9768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9768,1,3,0)
 ;;=3^Mammographic Calcification on Dx Breast Image
 ;;^UTILITY(U,$J,358.3,9768,1,4,0)
 ;;=4^R92.1
 ;;^UTILITY(U,$J,358.3,9768,2)
 ;;=^5019710
 ;;^UTILITY(U,$J,358.3,9769,0)
 ;;=R92.0^^39^417^67
 ;;^UTILITY(U,$J,358.3,9769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9769,1,3,0)
 ;;=3^Mammographic Microcalcification on Dx Breast Image
 ;;^UTILITY(U,$J,358.3,9769,1,4,0)
 ;;=4^R92.0
 ;;^UTILITY(U,$J,358.3,9769,2)
 ;;=^5019709
 ;;^UTILITY(U,$J,358.3,9770,0)
 ;;=N89.8^^39^417^72
 ;;^UTILITY(U,$J,358.3,9770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9770,1,3,0)
 ;;=3^Noninflammatory Vaginal Disorder,Oth Spec
 ;;^UTILITY(U,$J,358.3,9770,1,4,0)
 ;;=4^N89.8
 ;;^UTILITY(U,$J,358.3,9770,2)
 ;;=^88111
 ;;^UTILITY(U,$J,358.3,9771,0)
 ;;=R10.2^^39^417^82
 ;;^UTILITY(U,$J,358.3,9771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9771,1,3,0)
 ;;=3^Pelvic & Perineal Pain
 ;;^UTILITY(U,$J,358.3,9771,1,4,0)
 ;;=4^R10.2
 ;;^UTILITY(U,$J,358.3,9771,2)
 ;;=^5019209
 ;;^UTILITY(U,$J,358.3,9772,0)
 ;;=N94.89^^39^417^83
 ;;^UTILITY(U,$J,358.3,9772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9772,1,3,0)
 ;;=3^Pelvic Congestion Syndrome
 ;;^UTILITY(U,$J,358.3,9772,1,4,0)
 ;;=4^N94.89
 ;;^UTILITY(U,$J,358.3,9772,2)
 ;;=^5015925
 ;;^UTILITY(U,$J,358.3,9773,0)
 ;;=Z85.3^^39^417^57
 ;;^UTILITY(U,$J,358.3,9773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9773,1,3,0)
 ;;=3^Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,9773,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,9773,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,9774,0)
 ;;=Z85.43^^39^417^58
 ;;^UTILITY(U,$J,358.3,9774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9774,1,3,0)
 ;;=3^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,9774,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,9774,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,9775,0)
 ;;=N94.3^^39^417^81
 ;;^UTILITY(U,$J,358.3,9775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9775,1,3,0)
 ;;=3^PMS
 ;;^UTILITY(U,$J,358.3,9775,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,9775,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,9776,0)
 ;;=N93.0^^39^417^88
 ;;^UTILITY(U,$J,358.3,9776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9776,1,3,0)
 ;;=3^Postcoital & Contact Bleeding
 ;;^UTILITY(U,$J,358.3,9776,1,4,0)
 ;;=4^N93.0
 ;;^UTILITY(U,$J,358.3,9776,2)
 ;;=^5015914
 ;;^UTILITY(U,$J,358.3,9777,0)
 ;;=Z32.02^^39^417^91
 ;;^UTILITY(U,$J,358.3,9777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9777,1,3,0)
 ;;=3^Pregnancy Test,Negative
 ;;^UTILITY(U,$J,358.3,9777,1,4,0)
 ;;=4^Z32.02
 ;;^UTILITY(U,$J,358.3,9777,2)
 ;;=^5062850
 ;;^UTILITY(U,$J,358.3,9778,0)
 ;;=Z32.01^^39^417^92
 ;;^UTILITY(U,$J,358.3,9778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9778,1,3,0)
 ;;=3^Pregnancy Test,Positive
